The Kallikrein ( KLK ) gene locus encodes a family of serine proteases and is the largest contiguous cluster of protease-encoding genes attributed an evolutionary age of 330 million years. The KLK locus has been implicated as a high susceptibility risk loci in numerous cancer studies through the last decade. The KLK3 gene already has established clinical relevance as a biomarker in prostate cancer prognosis through its encoded protein, prostate-specific antigen. Data mined through genome-wide association studies (GWAS) and next-generation sequencing point to many important candidate single nucleotide polymorphisms (SNPs) in KLK3 and other KLK genes. SNPs in the KLK locus have been found to be associated with several diseases including cancer, hypertension, cardiovascular disease and atopic dermatitis. Moreover, introducing a model incorporating SNPs to improve the efficiency of prostate-specific antigen in detecting malignant states of prostate cancer has been recently suggested. Establishing the functional relevance of these newly-discovered SNPs, and their interactions with each other, through in silico investigations followed by experimental validation, can accelerate the discovery of diagnostic and prognostic biomarkers. In this review, we discuss the various genetic association studies on the KLK loci identified either through candidate gene association studies or at the GWAS and post-GWAS front to aid researchers in streamlining their search for the most significant, relevant and therapeutically promising candidate KLK gene and/or SNP for future investigations.
Introduction
Human genomic DNA is interspersed with many interindividual differences. These approximately 3 million variations, also called polymorphisms, are estimated to span around 0.1 % of the human genome (The International HapMap Consortium, 2007) . The single nucleotide polymorphisms (SNPs) representing approximately 90 % of all sequence variations is the most common type of variation in the human genome (Collins et al. , 1998 ) with a frequency of > 1 % in a given population. However, some researchers distinguish between ' polymorphic SNPs ' and ' common SNPs ' with a minor allele frequency of at least 5 % in the population (Brookes , 1999 ; Kruglyak and Nickerson , 2001 ; Ladiges et al. , 2004 ) .
Recent times have witnessed numerous candidate gene studies, which are restricted in the genes considered and the number of study subjects, and then whole-genome association studies (GWAS), making use of SNP arrays and elucidating various previously unknown disease-associated genes because of their unbiased advantage (Marian , 2012 ; Kote-Jarai et al., 2011b) . The GWAS technique is constantly evolving, with efforts being made towards overcoming previous drawbacks, such as population stratification, false positives and negatives, and replication difficulties. Moreover, recent access to next-generation sequencing platforms has revolutionized investigation in the field of the detailed investigation of the kallikrein gene locus and the genetic variants at this locus, and to uncover the functional aspects of this disease-associated region.
The KLK locus, which features among the seven highly-ranked susceptibility loci in a multi-stage prostate cancer GWAS , is clustered in a tan dem array of approximately 300 kilobases (kb) on chromosome 19q13.4, and contains the largest cluster of 15 homologous protease genes (Lawrence et al. , 2010 ) said to have evolutionarily emerged 330 million years ago (Clements , 2008 ; Pavlopoulou et al. , 2010 ) . With the recent imperative given to research on the KLK gene locus, many significant gene -disease associations have been established and previously unknown roles of KLK proteins elaborated. Since the initial observation that the three classical kallikreins -human kallikrein 1 (hk1/KLK1), human kallikrein 2 (hk2/KLK2) and PSA -are localized in this region, an additional 12 newly-discovered kallikreins have been mapped to the KLK locus (Paliouras and Diamandis , 2006 ) . Their secreted extracellular nature makes the KLK proteins potential targets as biomarkers that can easily be analyzed by the well-established enzyme-linked immunosorbent assay (ELISA) method. Apart from their importance as potential cancer biomarkers, their imprint has also been made in diseases like diabetes, skin disorders and neurodegenerative diseases (Paliouras and Diamandis , 2006 ) .
We have reviewed the genetic architecture, genetic isoforms, function and the role of kallikreins in disease metastasis in previous articles (Tan Olivia et al. , 2006 ; Lawrence et al. , 2007 Lawrence et al. , , 2010 . To the best of our knowledge, this article catalogs most of the identified SNPs within the KLK locus and reviews the role of these polymorphisms in various malignant and non-malignant diseases established in the context of gene-association studies conducted to date, with the objective of providing the readership with a consolidated resource on relevant SNPs in the KLK locus for future disease association studies.
KLK SNP data-mining from SNPdb and 1000 Genomes
We assessed all the SNPs recorded within ± 10 kb of the KLK locus mapped in Genome Build GRCh37/hg19 (chr19:51312404..51587502), from the most popular public database of SNPs, the National Center for Biotechnology Information ' s dbSNP (Sherry et al. , 2001 ) build 132, using the UCSC web-browser ( http://genome.ucsc.edu/ ). From a total of 4331 polymorphisms identified within the KLK locus, 3420 (73.4 % ) were found to be SNPs and 911 (26.6 % ) were genetic biomarkers by sharply reducing the cost of whole human-genome sequencing (Mardis , 2008a,b ; Schuster , 2008 ; Metzker , 2010 ; Davey et al. , 2011 ) . The ultimate goals of these studies are to get a better understanding of the molecular mechanisms underlying a disease and to provide the foundation for the development of sensitive and readily applicable lab-based screening tools. Such tools will be useful for clinical diagnosis and monitoring of treatment and prognosis, and will thus assist clinicians to obtain a more accurate and reliable assessment of metastatic disease and hopefully support clinical decision-making.
The past few years have also seen an expansion in resources available to researchers, providing them with open access information and online data mining from the extensive data accumulated through various international collaborative efforts. For example, the HapMap project provides a comprehensive SNP database, containing information on linked genomic regions (Olivier , 2003 ) . The 1000 Genomes Project (Siva , 2008 ; Pennisi , 2010 ) is an international collaboration to sequence the genomes of a substantial number of individuals to provide a comprehensive resource on human genetic variation and their haplotype blocks. The 1000 Genomes project ( http://www.1000genomes.org ), which is nearing completion, has already exceeded by half the number of novel SNPs observed by the HapMap project, i.e., with an estimate of more than 5.9 million variant nucleotide positions in the human genome. A total of 68 300 non-synonymous SNPs were identified through the 1000 Genomes pilot project, 34 161 of which were found to be novel. A fraction of these variations had been associated with various diseases and assigned a biological role, which is one step closer to establishing clinical relevance (Pennisi , 2010 ) . For example, a particular 7 SNP risk profile may aid in the management of BRCA2 mutation carriers in breast cancer (Antoniou et al. , 2010 ) , and a combination of several validated ' low-risk ' SNP markers has been proposed to be useful in breast cancer and prostate cancer risk prediction (Pharoah et al. , 2008 ; Zheng et al. , 2008 ) .
The protein-based indicator prostate-specific antigen (PSA), encoded by the KLK3 gene at the kallikrein (KLK) locus, is a well known and widely used oncogenic biomarker to diagnose and monitor prostate cancer progression after metastasis and treatment (Tan Olivia et al. , 2006 ; Lawrence et al. , 2010 ) . It has accrued many critics since its use, however, mostly due to its non specificity and accuracy in establishing aggressive prostate cancer prognosis over possible benign tumors, and on the identification of set threshold levels to determine the need for invasive techniques such as biopsies (Prensner et al. , 2012 ) , thus calling for a timely investigation to fine-tune the efficiency of PSA as a prostate cancer biomarker, possibly through insertion/deletion polymorphisms (indels) and/or mixed type. A similar study was published by Goard et al., in 2007 using custom designed tools ' ParSNPs ' and ' LocusAnnotator ' , which generated a catalog of 1856 polymorphisms of which 1023 were validated (Goard et al. , 2007 ) . While in our analysis a total of 2627 out of the 4331 polymorphisms were found to be validated (Nov, 2011) either by frequency, two-hit, submitter, cluster or by HapMap, which includes 2535 SNPs and 92 indels. (dbSNP uses certain validation methods to identify SNPs for their relevance. By frequency, where at least one submitted SNP in the cluster should have frequency data submitted; by cluster, which has two submissions with at least one submission assayed with a non-computational method; by submitter, with at least one submitter validated by independent assay. By two-hit/two-allele signifies that all alleles have been observed in at least two chromosomes). Five-hundred-seventy-four SNPs out of 2627 have recently been discovered from the 1000 Genomes database (Siva , 2008 ; Pennisi , 2010 ) . A total of 2150 SNPs were shown to have a minor allele frequency (MAF) > 1 % in the European population.
Our further analysis was restricted to validated polymorphisms only in an attempt to avoid analysis of falsepositive records in the dbSNP database that might have arisen due to sequencing artifacts. Based on the nature of their alleles, 1678 (66.2 % ) out of the 2535 validated SNPs in the KLK locus (66.2 % ) were C → T transitions (or G → A on the opposite strand), and 464 (18.3 % ) were C → A (G → T on the opposite strand), while 234 (9.2 % ) and 148 (5.8 % ) were C → G and T → A transversions, respectively. The records for 11 SNPs, which were reported to constitute more than two alleles, were not classified in the above groups. Considering the functional effects of SNPs based on their position to the nearest gene, and as defined by the UCSC browser, the most prevalent class annotations corresponded to those lying in non-coding intronic class (678/2535; 26.7 % ), untranslated region (113, 4.5 % ) and gene locus region polymorphisms (241, 9.5 % , present near the 3 ' or 5 ' of the gene). A smaller proportion of polymorphisms were associated with coding regions in the KLK locus (97/2535; 3.8 % ), with 35 % synonymous, 62 % missense and 3 % nonsense changes. The remaining polymorphisms not attributed to any position class by dbSNP (1406/2535; 55.4 % ) may refer to either intergenic or unannotated polymorphisms (Figure 1 ).
Functional KLK SNPs: in silico annotation
Functional SNPs are those polymorphisms that, depending on their position with respect to a protein coding region and/or a regulatory site, can affect the gene function and thus have a tendency to alter the cellular processes and functioning of the cell. Figure 2 details various web-based tools that can be used for the detailed in silico prediction and analysis of potential functional roles of the KLK SNPs. To this end, data for 1404 out of 2535 SNPs were retrieved using ' FuncPred ' ( http://snpinfo.niehs.nih.gov/snpfunc. htm ) from the SNPinfo web-server ( http://manticore.niehs. nih.gov/snpfunc.htm ), which assesses multiple functional prediction programs as well as calculating the regulatory potential score and conservation scores of SNPs (i.e., protein stability, splicing regulation, transcriptional regulation and post-translational modification), but lacking updated SNPs information from the 1000 Genomes project. Fourteen SNPs (rs11670728, rs12974899, rs12978483, rs2569522, rs2659056, rs28384475, rs3212811, rs3212840, rs3212846, rs3760739, rs58876874, rs7252452, rs3212850 and rs3745541) were predicted to alter a transcription-factor binding site. Nine SNPs (rs1624358, rs16988799, rs2736433, rs28384475, rs35192866, Lee et al. , 2009b ) . Each single nucleotide polymorphism should be further examined for its functional effect with respect to each category (i.e., protein coding, splicing regulation, transcriptional regulation and post-translation) using a series of algorithms.
rs61752567, rs7259651, rs10403407 and rs2659094) were predicted to alter the exonic splicing enhancer sites and disturb splicing regulation, while six might abolish the splicing domain itself. The PolyPhen ( http://coot.embl.de/ PolyPhen/ ) tool used by FuncPred (Adzhubei et al. , 2010 ) estimated the structural and functional impact of an amino acid substitution and predicted five SNPs to be deleterious (rs1048328, rs198977, rs5515, rs10422897 and rs183854). The SNPs3D software (http://www.snps3d.org; Yue et al. , 2006 ) was used to predict any deleterious effect of SNPs on protein function, which it does by making predictions based on the estimated impact of a non-synonymous SNP on protein stability, or considering conservation of the given amino acid within a protein family. Eleven SNPs (rs17632542, rs5515, rs198977, rs6072, 3733402, rs3733402, rs4253325, rs4253379, rs2569527, rs1048328 and rs183854) were predicted to be affirmative in their deleterious effect on protein functionality by SNPs3D. Twenty-four SNPs were predicted to have a high conservation score of > 0.4 and three SNPs (rs7245858, rs2691209 and rs16989073) to have a score of 1. Another important class of functionally relevant SNPs are polymorphisms present at or near the micro-RNA binding sites of functional genes (miRSNPs) with the potential to interfere with miRNA function, thus affecting gene expression (Pelletier and Weidhaas, 2010) . Among the KLK SNPs, four (rs10426, rs2691258, rs58682039 and rs61269009) were predicted to alter miRNA-binding sites, as predicted by Miranda ( http://www.microrna.org/ microrna/home.do ), while the Sanger method ( http:// www.mirbase.org/ ) predicted nine miRSNPs (rs2411334, rs2569735, rs2659092, rs268883, rs4846, rs9524, rs12151211, rs1654555 and rs2232539) within the KLK locus.
Functional KLK SNPs: experimental validation
Apart from the various in silico methods mentioned above, naturally-occurring polymorphisms identified in many human KLK genes (e.g., KLK1, KLK2, KLK3 and KLK12 ) have had their functional role established through laboratory investigation, as summarized in Table 1 .
KLK1 activity has previously been reported to decrease in people with primary hypertension and to be partly inherited, which led to the investigation of the association of KLK1 exon 3 non-synonymous polymorphism Arg77His (dbSNP ID rs5515) with urinary KLK1 activity in hypertensive individuals (Slim et al. , 2002 ) . Out of the 66 patients analyzed, five who were heterozygous for the Arg77His polymorphism were seen to harbor statistically significant down-regulation of urinary KLK1 activity. In vitro functional analysis of the activity of the wild-type or polymorphic KLK1 protein confirmed this decreased activity in the presence of the histidine residue, and modeling using crystallographic data suggested this residue may alter substrate binding. The same laboratory performed a follow-up study of this finding in normotensive subjects and confirmed the reduced activity in those carrying the histidine allele (Slim et al. , 2002 PCR, polymerase chain reaction; RFLP, restriction fragments length polymorphism; SSCP, single-strand conformation polymorphism; SNP, single nucleotide polymorphism.
addition, the individuals heterozygous for Arg77His also showed inappropriate remodeling of the brachial artery, which suggested implications for cardiovascular disease (Azizi et al. , 2005 ) . These studies support the finding of SNP rs5515 in the in silico analysis mentioned above, which also predicted it to possibly be deleterious. Another KLK1 coding SNP, Gln145Glu (rs5516), was not shown to affect urinary KLK1 activity in this study (Slim et al. , 2002 ) .
Incidentally, a functional analysis in 1997 reported SNPs/ fragment length polymorphism in the promoter region of KLK1 (between -133 and -121 with respect to the transcription initiation site) to be associated with decreased KLK1 gene expression (Table 1; Song et al. , 1997 ) . KLK2 displays a common coding region polymorphism that substitutes Arg250 for a tryptophan residue (rs198977). Experimental analysis using recombinant KLK2 in insect cells revealed a lack of trypsin-like activity by the polymorphic KLK2 protein (Table 1; Herrala et al. , 1997 ) . The rs198977 SNP has also been shown to be associated with significantly decreased levels of serum KLK2 in two large studies (Nam et al. , 2003 ; Klein et al. , 2010 ) , and our in silico analyses in the last subsection indicated a possibly damaging/deleterious effect. This SNP has been the subject of much investigation in relation to prostate cancer risk and will be discussed later in this review.
The KLK3 rs266882 SNP is one of the most interesting functional SNPs in the context of prostate cancer susceptibility. Residing within one of the androgen response elements (AREs) of KLK3 , ARE1, various studies have reported its association with increased serum PSA levels (Xue et al. , 2001 ; Medeiros et al. , 2002 ; Xu et al. , 2002 ; Rao et al. , 2003 ; Schatzl et al. , 2005 ) . Functional studies on rs266882 attribute KLK3 gene expression alteration to differential binding of ARE1 to the androgen receptor (Table  1) and enhanced transcriptional response to androgens. They also show increased prostate cancer susceptibility in the presence of A/A genotype (three-fold risk) and A/G genotype (2.4-fold risk; Lai et al. , 2007 ) .
Vasilopoulos et al. investigated the KLK7 3 ' untranslated region AACCins5874 insertion polymorphism for functional effects on KLK7 expression and observed an increased expression in the presence of the insertion (Table 1; Vasilopoulos et al. , 2011 ) , although no convincing association of this polymorphism with disease has been established to date.
The KLK12 intronic c.457 + 2T > C polymorphism, i.e., a T to C substitution in the second nucleotide of intron 2, was claimed to be associated with a splicing abnormality (Table 1) , with the expression of the human KLK12 classical mRNA and the protein (hK12/KLK12) corresponding to the putative serine protease being absent in individuals with a c.457 + 2C/C genotype but not in individuals with the T/T or T/C genotypes (Shinmura et al. , 2004 ) . However, the small number (n = 22) of samples considered in the analysis cells for replication in a larger set for results to be validated and conclusively confirmed.
Additional experimental studies are required to validate the functional role of the SNPs shortlisted by the in silico methods mentioned above.
Genetic architecture of the KLK locus: haplotypes and tagging
Alleles of SNPs in close physical proximity to each other are often correlated, and can be represented as haplotypes. Linkage disequilibrium (LD) is the occurrence of some combinations of alleles within a population more or less often than would be expected from a random formation of haplotypes from alleles (Devlin and Risch , 1995 ) . LD is represented by an r 2 or a D ' value, which is calculated based on the difference between observed and expected allelic frequencies (assuming random distributions). Geneticists commonly use the threshold of r 2 > 0.8 to measure which SNPs are in LD with other SNPs. To draw the LD map of the KLK locus, we used the HapMap Public Release 27, Build 36 ( http://hapmap.ncbi.nlm.nih. gov/cgi-perl/gbrowse/hapmap27_B36/#search ). All database SNPs within the Centre d'Etude du Polymorphisme Humain (CEPH) population (Utah residents with ancestry from northern and western Europe) were plotted using the Haploview 4.2 software (http://www.broadinstitute.org/ scientific-community/science/programs/medical-andpopulation-genetics/haploview/downloads; Barrett et al. , 2005 ) .
A total of 262 SNPs were genotyped in HapMap for a total of 205 individuals; 19 SNPs had a frequency of < 0.01, and so were not included in haplotype analysis. A total of 33 LD blocks were identified for the 15 KLK genes, as shown in Figure 3 . A tag SNP is a representative of a group of SNPs in a region of the genome with high LD. Tag SNPs are useful in whole-genome SNP association studies (described in detail later) as it is then possible to confidently predict genotypes for a number of different SNPs without assessing every SNP in a chromosomal region. The number of tagging SNPs within the KLK loci required to represent those HapMap SNPs with a frequency of < 0.01 was determined using the ' Tagger ' functionality with Haploview by means of a pairwise analysis of LD with an r 2 threshold of 0.8. Genotyping of 156 representative tagging SNPs is required to cover the 243 KLK variants based on a pairwise analysis of LD with an r 2 threshold of 0.8. As discussed above, the 1000 Genomes project is identifying many more genetic variants than those included in the HapMap database, and hence a vastly refined LD map of the KLK locus can be produced when the data are released in a user-friendly format.
Recently, Parikh et al. (2010) generated a comprehensive LD map of common SNPs and indels through deep sequencing analysis of a 56 kb region covering the KLK15 -KLK3 -KLK2 genes (chr 19: 56,019,829-56,076,043 bp; NCBI Build 36.3) in 78 unrelated individuals of European ancestry. A total of 555 polymorphic loci were identified, including 116 novel SNPs and 182 novel indels. Based on tagging analysis, 144 SNPs are necessary to tag the region at an r 2 threshold of 0.8 and MAF of 1 % or higher, while 86 loci are required to tag all SNPs with a MAF > 5 % . Further, these sequence data augment coverage of this region by only 35 % and 78 % compared to variants in dbSNP and HapMap, respectively. Thus, additional studies on LD mapping and tag SNP selection based on deep sequencing data are highly recommended.
Genetic association studies and KLK SNPs
Numerous studies have been performed to investigate SNPs found in the KLK genes for their malignant and non-malignant disease associations. The majority of SNP association studies have focused on their effects on cancer risk, particularly prostate cancer. Presumably, this was originally because of the identification of PSA/ KLK3 in the etiology of this disease, and more recently because of results from large genome-wide studies implicating this locus in prostate cancer risk. Below we review the various SNP association studies carried out to determine disease susceptibility and the methods used to perform these analyses. The genotyping for the association studies was conducted on blood genomic DNA unless otherwise specified.
Association studies on low risk variants in KLK genes
Inherited genetic variants can be segregated into two categories: rare high-risk genetic variants (or mutations) and common low-risk genetic variants, such as SNPs. This review subsequently focuses on common, low-risk genetic variants or SNPs of the KLKs and the genetic approaches used to identify these. While these SNPs have much weaker effects than high-risk genetic mutations, they are common and may have a large population attributable risk ( > 5 % ) and together could contribute to a complex disease phenotype (Pestell , 2008 ) . A complete and detailed list of SNPs analyzed in gene-association studies in previous research initiatives, including those that failed to reach statistical significance, has been included in the supplementary tables.
Pre-GWAS KLK candidate gene-association studies
Prior to 2007, the candidate-gene approach was the predominant method used to explore inherited low-risk genetic variants. This approach is based on a priori knowledge about the gene(s) of interest in the pathogenesis of the phenotype and involves an examination of a relatively small number of genetic variants (between 1 and 100 SNPs; Savage , 2008 ) . The approach has led to the identification of a number of SNPs that may influence the risk of hormone-related cancers, particularly prostate cancer, with instances of ovarian cancer and breast cancer, as listed in Table 2 .
The most frequently analyzed KLK SNP before 2008 was rs266882 (G-158A) in the KLK3 locus; a significant association with prostate cancer risk for this SNP was originally reported by Xue et al., in 2000 (Table 2 ). Numerous subsequent studies have revealed conflicting results. Some have reported an association with the same allele as the original study (Gsur et al. , 2002 ; Medeiros et al. , 2002 ; Cicek et al. , 2005 ; Lai et al. , 2007 ) , while others have reported either a significant association in the opposite direction (Chiang et al. , 2004 ; Binnie et al. , 2005 ) or no association for this SNP (Wang et al. , 2003 ; Salinas et al. , 2005 ; Mononen et al. , 2006 ; Severi et al. , 2006 ; Cunningham et al. , 2007 ; Pal et al. , 2007 ; Penney et al. , 2011 ) . A meta-analysis of all studies published up until 2008 reported no evidence of association with prostate cancer risk overall (Supplementary Table 1 ; Jesser et al. , 2008 ) .
Currently, significant associations have been reported for SNPs located within KLK2 , KLK3 , KLK4 , KLK10 and KLK15 with breast cancer, ovarian cancer survival and prostate cancer. Genes and significant SNPs of KLK2 (rs198977, rs2664155 and rs1506684), KLK4 (rs806019), KLK10 (rs3745535) and KLK15 (rs266851) found to be associated with cancer risk or prognosis are detailed in Regarding the potential role of polymorphisms in noncancerous diseases, KLK1 has been the most intensively studied KLK gene, perhaps because it was the first KLK gene to be discovered. Of the 13 different non-malignant diseases and traits investigated in KLKs (Table 3 ) , the role of KLK1 in cardiovascular and kidney-related diseases has been the focus of the majority of studies. A candidate gene association study for the functional SNP rs5515 with risk of cardiovascular traits/disease did not report any association in the two small candidate SNP studies performed to date (Supplementary Table 2 ). Perhaps the most compelling finding arose from research into hypertension in the Chinese Han population, with several KLK1 polymorphisms indicating an increased cardiovascular traits/disease risk (Table 3,  Supplementary Table 2 ; Hua et al. , 2005 ; Zhao et al. , 2007 ) . Other examples of disease associations include KLK4 for AIH IIA1, KLK7 for atopic dermatitis, and KLK8 for intracranial aneurysm, details of which can be found in Table 3 .
A recent small cohort study (cases = 218 and controls = 220) by Lee et al., performed pyrosequencing to genotype the SNP site ( + 255G > A, rs2664155) in intron 1 of the KLK2 gene. A statistically significant association between rs2664155 and male infertility (OR = 0.47, 95 % CI = 0.26 -0.85, p < 0.05) was reported (Lee and Lee , 2011 ) , although no functional analysis towards this risk susceptibility has been carried out to date.
Unless performed in a very large sample size from a well-characterized population, the candidate-gene approach is prone to spurious results. This is evident by the number of follow-up studies performed that have attempted to validate positive reports of KLK polymorphism disease associations that have, however, failed to confirm original results (Supplementary Tables 1 and 2 ).
KLK genes in genome-wide association studies
Since around 2007, genetic epidemiology has been transformed by the availability of high-throughput genotyping methods designed to provide an unbiased survey on the effects of common genetic variants, called GWAS. GWAS are studies wherein research subjects are typed for a large number of genetic variants, typically between 300 000 and 1 000 000 polymorphisms, and the allele or genotype frequencies are evaluated for differences between groups (e.g., disease vs. non-disease groups). The advantage of GWAS is that they allow for a wide search of genetic variants associated with disease without having to specify a particular gene of interest, facilitating the mining of potentially novel variants (Wellcome Trust Case Control Consortium , 2007 ) . Due to the massive number of joint statistical tests performed, however, there is a higher level of type-1 error (false-positives). Statistical corrections for multiple hypotheses testing are therefore essential and a p < 10 -7 has been proposed as an appropriate significance level for evidence of a genome-wide association (Thomas et al. , 2005 ) . This means that large sample sizes are required for GWAS to ensure adequate statistical power to detect an association with small p -values. Since the advent of GWAS technology, highly statistically significant and robust associations with SNPs in over 230 diseases and traits have been successfully identified (Hindorff et al. , 2011 ; Table 4 ; Eeles et al. , 2008 ) . Following this discovery, there have been a large number of studies pursuing association studies of SNPs in the KLK region, examining both prostate cancer risk and prognostic features. The KLK gene associations found to be significant to prostate cancer susceptibility are summarized in Table 4 , with non-significant associations mentioned in Supplementary Table 3 . Relevant studies are discussed below.
The above GWAS-identified SNP, rs2735839, displayed a strong association with PSA levels (Table 4 ; Eeles et al. , 2008 ) . However, there has been some debate as to whether this SNP is truly associated with prostate cancer or simply relates to PSA expression levels, since male controls used for the stage 1 analysis were limited to those with clinically low PSA levels ( < 0.5 ng/ml; Ahn et al. , 2008 ) . Nevertheless, further investigation of rs2735839 in additional large case-control sample sets where controls were not screened for PSA levels did replicate the association (Kote -Jarai et al., 2008 ). There have been several studies performed to find more such risk alleles, assessing the association of SNPs in the KLK2 and KLK3 region with PSA and hK2/ KLK2 levels (Supplementary Table 4 ).
An evaluation study was carried out by Bensen et al. to determine SNP associations with prostate cancer aggressiveness in Afro-American and European-American men from the North Carolina-Louisiana Prostate Cancer Project. Genotyped DNA from blood and buccal cell samples demonstrated three SNPs in the KLK3 region (i.e., rs266870, Table 3 KLK genetic associations performed in non-malignant diseases.
CI, confidence interval; OR, odds ratio; PCR, polymerase chain reaction; RFLP, restriction fragments length polymorphism. Blood samples have been used for DNA extraction and genotyping in above studies, unless otherwise specified. *Blood and urine DNA.
rs1058205 and rs2735839) showing significant associations with prostate cancer risk and significantly associating with PSA levels in Afro-American men (Bensen et al., 2012) , as detailed in Table 4 . Even though no significant polymorphisms in KLK4 were identified relating to prostate cancer susceptibility, recent efforts by a multistage GWAS i.e., stages I and II of the Cancer Genetics Markers of Susceptibility Initiative have established gene interactions of rs2735839 (taken as a conditioning SNP) with rs1558874, which is intronic to PRRX2 ( p = 4.80E-5, multiplicative OR = 1.33), and rs17714461 ( p = 7.14E-4) located 15 kb from KLK4 and 60 kb from the conditioning SNP, although not demonstrating LD with it (r 2 < 0.001). Other notable interactions of rs2735839 were with rs17714461 (close to KLK4) and rs1558875, an intronic SNP to PRRX2 , both SNPs being implicated in prostate cancer cell proliferation by previous studies (Ciampa et al. , 2011 ) .
A study of the KLK12 gene locus (cases = 3153 and controls = 3199) established an association between rs3865443, a SNP in KLK12 having a marginal statistically significant association with prostate cancer risk, and a requirement for further validation in a larger sample group (Supplementary Table 3) .
Another recent interesting finding was that KLK14 was inversely androgen regulated in prostate cancer cells (Lose et al. , 2012 ) . The potential of this gene in prostate cancer prognosis is promising, with the further identification of three SNPs around the KLK14 locus being associated with prostate cancer aggression. The SNPs were rs17728459 and rs4802765, located 9 kb and 2 kb upstream of KLK14, respectively, and rs35287116, which encodes a p.Gln33Arg substitution in the KLK14 signal peptide region (Lose et al. , 2012 ) listed in Table 4 .
In the process of GWAS follow-up, our study of the Prostinogen ( KLK15 ) gene identified rs2659056 to be associated with tumor aggressiveness in a Queensland (QLD) study cohort (cases = 1011 and controls = 1405). This was again confirmed in replicate sets of UK GWAS stage 3 study. A highly significant association with Gleason score was observed in the combined analysis from different datasets (Table 4 ; Batra et al. , 2011a ) . However, further experiments are needed to establish the functional relevance of the RORalpha transcription-factor binding alteration predicted in silico by the study (Batra et al. , 2011a ) .
The intrinsic design of the GWAS means that significantly associated SNPs are seldom those that are causally linked to the phenotype, and are instead in LD with a functionally important variant. Identification of the causal variant is important for understanding of the molecular mechanisms underlying the pathogenesis of disease. Moreover, sincere efforts are being made to include various ' omics ' levels from a systems biology viewpoint (Quigley and Balmain , 2009 ), epigenetic considerations and gene-environment interactions to boost casual variant determination and also in the follow-up functional analysis of isolated SNPs in the post-GWAS era . Consequently, additional intensive studies are required to complement GWAS to identify disease-causing alleles and their functional role in pathogenicity, such as fine-mapping and imputation studies.
Fine-mapping studies on GWAS identified KLK SNPs
One method that can be used to identify causal SNPs involves the performance of fine-mapping studies. These involve examining the association of all known common sequence variants in the vicinity of the GWAS-identified SNP with the disease of interest. Appropriate common sequence variants may be identified by accessing SNP databases, using sequencing data from the 1000 Genomes project, or by performing re-sequencing studies of the region of interest. As discussed previously, Parikh et al. (2010) performed deep sequencing analysis of a 56 kb region flanking the GWAS-identified prostate cancer risk SNP rs2735839 in KLK3 . Using these sequencing results, they then selected 24 SNPs to tag the region surrounding rs2735839 and geno typed these in five prostate cancer case-control studies from the US, France, Norway and Finland (cases = 3522 and controls = 3338; Parikh et al. , 2011 ) . While no strong association was observed with the original KLK3 variant, rs2735839 ( p = 0.20), there was evidence of an association of three highly-correlated SNPs (rs17632542, rs62113212 and rs62113214) with prostate cancer risk (rs17632542 per allele OR 0.7, 95 % CI = 0.67 -0.89, p = 3.41×10 -4 ). When stratified by disease aggressiveness, an association was only observed among less severe prostate cancer cases (Gleason score < 7 and disease stage < III). The rs17632542 SNP is potentially functional, introducing a non-synonymous amino acid change from isoleucine (hydrophobic) to threonine (polar) at position 179 of the KLK3 protein. This amino acid is conserved in humans, chimpanzee and rhesus monkeys but not in other mammals or vertebrates. It is unclear whether this amino acid change has a benign or neutral functional impact and it is currently being investigated (Parikh et al. , 2011 ) .
Imputation: a new tool for fine-mapping studies
Another method that can be used to refine GWAS signals and identify causal SNPs is imputation. Genotype imputation is the process of predicting (or imputing) genotypes for known variants that are not directly assayed in a sample of individuals. These ungenotyped variants can then be tested for association with the trait. Imputation involves the comparison of study samples genotyped for a relatively large number of genetic markers (100 000 -1 000 000 SNPs) to a reference panel of haplotypes derived from a number of individuals genotyped at all markers of interest (Browning , 2008 ) . To date, the HapMap database has typically served as this reference panel, with Phase II of this project (Frazer et al. , 2007 ) including over 3.1 million SNPs genotyped on four panels of individuals. Other reference panels, such as the 1000 Genomes project, have recently been made available.
A recent paper by Kote -Jarai et al. (2011a) undertook an imputation approach to refine the association between SNPs in the KLK3 GWAS-identified region and prostate cancer. Using genotyping data from a two-stage GWAS using British and Australian samples (Eeles et al. , 2009 ) and the Cancer Genetic Markers of Susceptibility study ( http://www.cgems.cancer.gov/ ), genotypes were imputed for 197 and 312 SNPs from HapMap Phase II and the 1000 Genomes project, respectively. Interestingly, the same previously unreported SNP identified in the fine mapping study by Parikh et al., in 2011, rs17632542 , was also found to be strongly associated with prostate cancer risk in this study. The association was subsequently confirmed by direct genotyping of 10 405 cases and 10 681 control individuals from the three stages of the British/Australian GWAS. This association remained strong after adjusting for the GWAS-identified SNP rs2735839 ( p = 8.5 × 10 -14 ). The authors suggest rs17632542 to be the most plausible functional variant and multiple molecular dynamic simulations revealed that the threonine variant displayed superior stability in solution with likely displacement of the kallikrein loop (Kote -Jarai et al., 2011a ). The functional consequences of these in silico findings are yet to be established.
Aside from prostate cancer, the KLK locus has not specifically been identified by GWAS to be associated with any other disease or trait. Coverage of genetic variation in the KLK locus by the genotyping chips used in these studies is quite poor, however, ranging from just 6 % of the SNPs in the KLK9 gene to 55 % in the KLK14 gene (Lose and Batra, unpublished data) . Hence, more comprehensive and targeted investigations of SNPs in the KLK locus and various diseases are still warranted. In addition, the majority of GWAS studies have been performed in Caucasian subjects, thus genome-wide studies of Asian and African/African-American populations may yet reveal or confirm a role for the KLKs in other diseases.
Association studies on high-risk variants in KLK genes
Rare genetic variants are considered to have a larger phenotypic effect on disease risk. As lethal variations are not favorable to propagation through natural selection, many of these have been identified using family-based studies (Marian , 2012 ) . Rare variants were commonly overlooked in GWAS analysis due to their inability to reach statistical significance relative to other common variants. Thus there was a conceptual shift of hypothesis from common disease to common variant (CD -CV) to rare variants to common disease (RV -CD). This has been guiding next-generation sequencing measures to direct focus towards high-risk variants in order to establish complex disease associations (Marian , 2012 ) .
Only one KLK gene, KLK4 , has successfully been identified as containing a high-risk, disease-causing mutation. Amelogenesis imperfecta (AI) -hypomaturation type IIA1, as listed in Table 3 , is a disorder of the teeth that results from incomplete mineralization of tooth enamel. KLK4 was shown to be one of several factors critical for normal enamel formation (Simmer and Hu , 2002 ) and was therefore investigated for mutations in AI families. The initial study identified a truncating mutation, p.W153X, in one AI family that occurs at a highly conserved tryptophan residue and results in a KLK4 protein lacking the S207 residue of the catalytic triad (Hart et al. , 2004 ) . Two further AI studies carried out using DNA from blood and saliva samples have identified several more Caucasian families carrying this mutation (Wright et al. , 2009 (Wright et al. , , 2011 , cementing KLK4 as a high-risk gene for this condition.
Conclusions
Genetic variation in the kallikrein genes has been a popular focus for human disease research since their discovery. Initially, many conflicting results were observed, a phenomenon typical of candidate gene studies at the time. Since the advent of genome-wide association studies involving large numbers of patients and controls, quite promising results have arisen, particularly those implicating SNPs around KLK2 and KLK3 in prostate cancer risk. Although it is not likely that KLK SNP(s) alone will be useful in a clinical setting without the incorporation of SNPs from other loci and/or additional variables, particular KLK SNPs may one day form part of rapid, germline DNA-based clinical tests that may be able to stratify patients at a high risk of developing prostate cancer from those with a very low prostate cancer risk.
